Search Results for “EC” – Page 624 – media

Europe’s first stem cell therapy backed by NICE

Chiesi's Holoclar, the first stem-cell therapy to be cleared by European regulators, has received a green light for use on the NHS in England and Wales to treat a rare sight condition.
- Source: pharmatimes
- 842
- August 29, 2017
New Approvals NHS stem-cell therapy
Resonetics Acquires Aduro Laser, Adds Disruptive Manufacturing Capability for Laser Cut Tubing

Resonetics announced today its acquisition of Aduro Laser, an emerging leader in laser processing of tubular components for the medical device industry.
- Source: prnewswire
- 510
- August 29, 2017
acquisition Company Insight laser Market Views
“Body-on-a-chip” device screens human heart cells for drug toxicity

A "body-on-a-chip" device that can evaluate the side-effects of drugs on human cells has been developed by researchers at Kyoto University's Institute for Integrated Cell-Material Sciences, according to a study published today in the Royal Society of Chemistry Advances.
- Source: drugdeliverybusiness
- 585
- August 29, 2017
doxorubicin Researches side-effect toxicity
Ddu Attended Pharma Asia-Boosting the Belt and Road Initiative

The 13th Health Asia & Pharma Asia International Exhibition & Conferences (Pharma Asia) was held at the Karachi Expo Center from August 22nd to August 24th 2017. As the leading global pharmaceutical and medical device B2B online platform, Ddu attended the exhibition introducing their new cross-border medical trade online method to Pakistan.
- Source: Ddu
- 831
- August 29, 2017
Exhibitions & Activities Pakistan Pharma Asia
Ddu Attended the 2017 CPhI Korea-Establishing a Good Reputation for Services

The 2017 CPhI Korea was grandly held at the Convention Center Grand Ball Room, Seoul, South Korea from August 22nd to August 24th. Ddu, the leading global pharmaceutical and medical device B2B online platform, attended the exhibition where their management concept and service method proved why they are a leader in their field.
- Source: Ddu
- 1,194
- August 29, 2017
CPhI Exhibitions & Activities Korea
US OKs first drug for dyskinaesia in Parkinson’s patients

US regulators have approved the first and only treatment option to treat dyskinaesia in patients with Parkinson's disease.
- Source: pharmatimes
- 696
- August 28, 2017
dyskinaesia New Approvals Parkinson
US researchers develop anastomosis tool using medical magnets

A new anastomosis tool using a pair of medical magnets has been developed by researchers at the University of California, San Francisco, US.
- Source: medicaldevice-network
- 547
- August 28, 2017
anastomosis Clinical Trials surgical
Takeda partners to develop novel oncology therapies

Collaboration on an oncology drug discovery program was inked between Takeda Pharmaceutical, through its subsidiary Millennium Pharmaceuticals, and Molecular Templates.
- Source: drugdeliverybusiness
- 829
- August 28, 2017
Company Insight Market Views oncology therapy
Merck sees promise in Macrophage Pharma

Merck Ventures has become the latest group to invest in Macrophage Pharma and take a position on the UK biotech’s board of directors.
- Source: pharmatimes
- 630
- August 25, 2017
Clinical Market Views Merck
Titan wins FDA nod to study Parkinson’s implant

Titan Pharmaceuticals’ stated today that their ropinirole implant, designed to treat the symptoms of Parkinson’s disease, was cleared by the FDA today as a new drug application.
- Source: drugdeliverybusiness
- 650
- August 25, 2017
Clinical Trials formulation implant New Approvals Parkinson

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.